Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review

Background and Purpose: The availability of oncology biosimilars is deemed as a fundamental strategy to achieve sustainable health care. However, there is scarce systematic evidence on economic effectiveness of cancer biosimilars. We aimed to synthesize evidence from pharmacoeconomic evaluation of o...

Full description

Bibliographic Details
Main Authors: Hui-Yao Huang, Cheng-Cheng Liu, Yue Yu, Le Wang, Da-Wei Wu, Lan-Wei Guo, Shu-Hang Wang, Hong Fang, Ying Bai, Yuan Fang, Qi Fan, Chao Sun, Ying Wu, Ju-Fang Shi, Fei Ma, Yu Tang, Min Dai, Ning Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.572569/full